RTTNews | Jul 13, 2020 04:45PM EDT

04:45 Monday, July 13, 2020

|BEGINSUB|Asian Shares Rise On Vaccine Hopes|ENDSUB|Asian stocks advanced on Monday as hopes for a quick economic recovery as well as reports of positive data in early stage coronavirus vaccine trials helped offset worries about a continued surge in new coronavirus cases worldwide.

|BEGINSUB|European Markets Close On Buoyant Note On Vaccine Hopes|ENDSUB|Despite another sharp surge in new cases of coronavirus infection around the world over the weekend, European markets closed higher on Monday, as investors picked up stocks amid growing optimism about potential coronavirus vaccines.

|BEGINSUB|Tech Stocks Lead Sharp Afternoon Pullback On Wall Street|ENDSUB|Stocks showed a strong move to the upside in morning trading on Monday but pulled back sharply over the course of the afternoon. The tech-heavy Nasdaq showed a particularly steep drop after reaching a new record intraday high.

|BEGINSUB|Stock Alert: Maxim Integrated Hits New 52-week High On Acquisition By Analog Devices |ENDSUB|Shares of Maxim Integrated Products, Inc. are climbing more than 12 percent or $7.97 in Monday's morning trade at $72.06, after earlier touching a new 52-week high of $72.84.

Monday, semiconductor makers Analog Devices, Inc. (ADI) and Maxim said they have entered into a definitive agreement under which ADI will acquire Maxim in an all-stock transaction that values the combined enterprise at over $68 billion. The transaction is expected to close in the summer of 2021.

|BEGINSUB|Stock Alert: NextCure Tumbles To New 52-week Low |ENDSUB|Shares of NextCure, Inc. (TS:NXTC) are losing more than 41 percent or $7.36 in Monday's morning trade at $10.52, after earlier touching a new 52-week low of $10.45.

Monday, Beltsville, Maryland-based NextCure NextCure provided an interim update of the Phase 2 portion of its NC318 Monotherapy phase 1/2 trial.

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved